ID   OXSR1_HUMAN             Reviewed;         527 AA.
AC   O95747; Q3LR53; Q7Z501; Q9UPQ1;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   12-OCT-2022, entry version 197.
DE   RecName: Full=Serine/threonine-protein kinase OSR1;
DE            EC=2.7.11.1;
DE   AltName: Full=Oxidative stress-responsive 1 protein;
GN   Name=OXSR1 {ECO:0000312|HGNC:HGNC:8508};
GN   Synonyms=KIAA1101 {ECO:0000312|EMBL:BAA83053.2}, OSR1
GN   {ECO:0000312|EMBL:BAA75674.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAA75674.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT ILE-304.
RC   TISSUE=Skeletal muscle {ECO:0000312|EMBL:BAA75674.1};
RX   PubMed=10083736; DOI=10.1007/s100380050121;
RA   Tamari M., Daigo Y., Nakamura Y.;
RT   "Isolation and characterization of a novel serine threonine kinase gene on
RT   chromosome 3p22-21.3.";
RL   J. Hum. Genet. 44:116-120(1999).
RN   [2] {ECO:0000312|EMBL:BAA83053.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000312|EMBL:BAA83053.2};
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAP97192.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-304 AND THR-425.
RG   NIEHS SNPs program;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000312|EMBL:AAH08726.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH08726.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAP97192.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 172-527.
RA   Ding J.B., Yu L., Gong R.M., Mao N.H., Han X.F., Zhao S.Y.;
RT   "Cloning and characterization of a novel human cDNA homologous to human
RT   DCHT mRNA.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305}
RP   FUNCTION, AUTOPHOSPHORYLATION, ACTIVITY REGULATION, INTERACTION WITH PAK1,
RP   AND MUTAGENESIS OF LYS-46.
RX   PubMed=14707132; DOI=10.1074/jbc.m313562200;
RA   Chen W., Yazicioglu M., Cobb M.H.;
RT   "Characterization of OSR1, a member of the mammalian Ste20p/germinal center
RT   kinase subfamily.";
RL   J. Biol. Chem. 279:11129-11136(2004).
RN   [7]
RP   FUNCTION, INTERACTION WITH RELL1; RELL2 AND RELT, AND MUTAGENESIS OF
RP   LYS-46.
RX   PubMed=16389068; DOI=10.1016/j.bbrc.2005.12.033;
RA   Cusick J.K., Xu L.-G., Bin L.-H., Han K.-J., Shu H.-B.;
RT   "Identification of RELT homologues that associate with RELT and are
RT   phosphorylated by OSR1.";
RL   Biochem. Biophys. Res. Commun. 340:535-543(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339 AND SER-427, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339 AND SER-347, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339 AND SER-427, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22361696; DOI=10.1016/j.jprot.2012.01.030;
RA   Stadler C., Hjelmare M., Neumann B., Jonasson K., Pepperkok R., Uhlen M.,
RA   Lundberg E.;
RT   "Systematic validation of antibody binding and protein subcellular
RT   localization using siRNA and confocal microscopy.";
RL   J. Proteomics 75:2236-2251(2012).
RN   [18]
RP   FUNCTION, INTERACTION WITH PLSCR1, AND AUTOPHOSPHORYLATION.
RX   PubMed=22052202; DOI=10.1007/s11010-011-1127-4;
RA   Cusick J.K., Mustian A., Jacobs A.T., Reyland M.E.;
RT   "Identification of PLSCR1 as a protein that interacts with RELT family
RT   members.";
RL   Mol. Cell. Biochem. 362:55-63(2012).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-310; SER-324; SER-325;
RP   SER-339 AND SER-359, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   FUNCTION.
RX   PubMed=28688764; DOI=10.1016/j.bbrc.2017.07.022;
RA   Moua P., Checketts M., Xu L.G., Shu H.B., Reyland M.E., Cusick J.K.;
RT   "RELT family members activate p38 and induce apoptosis by a mechanism
RT   distinct from TNFR1.";
RL   Biochem. Biophys. Res. Commun. 491:25-32(2017).
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-304 AND SER-433.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Phosphorylates RELL1, RELL2 and RELT (PubMed:16389068,
CC       PubMed:28688764). Phosphorylates PAK1 (PubMed:14707132). Phosphorylates
CC       PLSCR1 in the presence of RELT (PubMed:22052202).
CC       {ECO:0000269|PubMed:14707132, ECO:0000269|PubMed:16389068,
CC       ECO:0000269|PubMed:22052202, ECO:0000269|PubMed:28688764}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:14707132};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:14707132};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:14707132};
CC   -!- ACTIVITY REGULATION: By autophosphorylation on threonine.
CC       {ECO:0000269|PubMed:14707132}.
CC   -!- SUBUNIT: Interacts with PAK1 (PubMed:14707132). Interacts with chloride
CC       channel proteins SLC12A6 isoform 2, SLC12A1 and SLC12A2 but not with
CC       SLC12A4 and SLC12A7, possibly establishing sensor/signaling modules
CC       that initiate the cellular response to environmental stress (By
CC       similarity). Interacts with RELL1, RELL2 and RELT (PubMed:16389068).
CC       Interacts with PLSCR1 in the presence of RELT (PubMed:22052202).
CC       {ECO:0000250|UniProtKB:Q6P9R2, ECO:0000269|PubMed:14707132,
CC       ECO:0000269|PubMed:16389068, ECO:0000269|PubMed:22052202}.
CC   -!- INTERACTION:
CC       O95747; Q6ZMQ8: AATK; NbExp=2; IntAct=EBI-620853, EBI-2008380;
CC       O95747; Q9Y376: CAB39; NbExp=3; IntAct=EBI-620853, EBI-306905;
CC       O95747; O95747: OXSR1; NbExp=3; IntAct=EBI-620853, EBI-620853;
CC       O95747; Q8NC24: RELL2; NbExp=7; IntAct=EBI-620853, EBI-10269209;
CC       O95747; P55011: SLC12A2; NbExp=3; IntAct=EBI-620853, EBI-2801449;
CC       O95747; Q9H4A3: WNK1; NbExp=8; IntAct=EBI-620853, EBI-457907;
CC       O95747; Q96J92: WNK4; NbExp=12; IntAct=EBI-620853, EBI-766352;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22361696}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed in all tissue examined.
CC       {ECO:0000269|PubMed:10083736}.
CC   -!- PTM: Autophosphorylated. {ECO:0000269|PubMed:14707132,
CC       ECO:0000269|PubMed:22052202}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAP97192.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA83053.2; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/oxsr1/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB017642; BAA75674.1; -; mRNA.
DR   EMBL; AB029024; BAA83053.2; ALT_FRAME; mRNA.
DR   EMBL; DQ201638; ABA27097.1; -; Genomic_DNA.
DR   EMBL; BC008726; AAH08726.1; -; mRNA.
DR   EMBL; AF087893; AAP97192.1; ALT_INIT; mRNA.
DR   CCDS; CCDS2675.1; -.
DR   RefSeq; NP_005100.1; NM_005109.2.
DR   PDB; 2V3S; X-ray; 1.70 A; A/B=433-527.
DR   PDB; 2VWI; X-ray; 2.15 A; A/B/C/D=1-303.
DR   PDB; 3DAK; X-ray; 2.25 A; A/B/C/D=6-295.
DR   PDB; 7OKW; X-ray; 1.62 A; A/B=423-527.
DR   PDBsum; 2V3S; -.
DR   PDBsum; 2VWI; -.
DR   PDBsum; 3DAK; -.
DR   PDBsum; 7OKW; -.
DR   AlphaFoldDB; O95747; -.
DR   SMR; O95747; -.
DR   BioGRID; 115269; 153.
DR   CORUM; O95747; -.
DR   DIP; DIP-34977N; -.
DR   ELM; O95747; -.
DR   IntAct; O95747; 35.
DR   MINT; O95747; -.
DR   STRING; 9606.ENSP00000311713; -.
DR   BindingDB; O95747; -.
DR   ChEMBL; CHEMBL1163104; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; O95747; -.
DR   iPTMnet; O95747; -.
DR   PhosphoSitePlus; O95747; -.
DR   SwissPalm; O95747; -.
DR   BioMuta; OXSR1; -.
DR   EPD; O95747; -.
DR   jPOST; O95747; -.
DR   MassIVE; O95747; -.
DR   MaxQB; O95747; -.
DR   PaxDb; O95747; -.
DR   PeptideAtlas; O95747; -.
DR   PRIDE; O95747; -.
DR   ProteomicsDB; 51019; -.
DR   Antibodypedia; 2101; 545 antibodies from 36 providers.
DR   DNASU; 9943; -.
DR   Ensembl; ENST00000311806.8; ENSP00000311713.3; ENSG00000172939.9.
DR   GeneID; 9943; -.
DR   KEGG; hsa:9943; -.
DR   MANE-Select; ENST00000311806.8; ENSP00000311713.3; NM_005109.3; NP_005100.1.
DR   UCSC; uc003chy.4; human.
DR   CTD; 9943; -.
DR   DisGeNET; 9943; -.
DR   GeneCards; OXSR1; -.
DR   HGNC; HGNC:8508; OXSR1.
DR   HPA; ENSG00000172939; Low tissue specificity.
DR   MIM; 604046; gene.
DR   neXtProt; NX_O95747; -.
DR   OpenTargets; ENSG00000172939; -.
DR   PharmGKB; PA134973207; -.
DR   VEuPathDB; HostDB:ENSG00000172939; -.
DR   eggNOG; KOG0582; Eukaryota.
DR   GeneTree; ENSGT00940000162134; -.
DR   HOGENOM; CLU_000288_111_1_1; -.
DR   InParanoid; O95747; -.
DR   OMA; TSNCKQG; -.
DR   OrthoDB; 789556at2759; -.
DR   PhylomeDB; O95747; -.
DR   TreeFam; TF105339; -.
DR   PathwayCommons; O95747; -.
DR   SignaLink; O95747; -.
DR   SIGNOR; O95747; -.
DR   BioGRID-ORCS; 9943; 18 hits in 1117 CRISPR screens.
DR   ChiTaRS; OXSR1; human.
DR   EvolutionaryTrace; O95747; -.
DR   GeneWiki; OXSR1; -.
DR   GenomeRNAi; 9943; -.
DR   Pharos; O95747; Tbio.
DR   PRO; PR:O95747; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; O95747; protein.
DR   Bgee; ENSG00000172939; Expressed in buccal mucosa cell and 207 other tissues.
DR   ExpressionAtlas; O95747; baseline and differential.
DR   Genevisible; O95747; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0071476; P:cellular hypotonic response; IEA:Ensembl.
DR   GO; GO:1990869; P:cellular response to chemokine; IMP:BHF-UCL.
DR   GO; GO:0038116; P:chemokine (C-C motif) ligand 21 signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0038146; P:chemokine (C-X-C motif) ligand 12 signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:1901017; P:negative regulation of potassium ion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0007231; P:osmosensory signaling pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0010820; P:positive regulation of T cell chemotaxis; IMP:BHF-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; TAS:ProtInc.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; IMP:ParkinsonsUK-UCL.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR024678; Kinase_OSR1/WNK_CCT.
DR   InterPro; IPR028749; Oxsr1.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   PANTHER; PTHR48012:SF1; PTHR48012:SF1; 1.
DR   Pfam; PF12202; OSR1_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cytoplasm; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22223895"
FT   CHAIN           2..527
FT                   /note="Serine/threonine-protein kinase OSR1"
FT                   /id="PRO_0000086456"
FT   DOMAIN          17..291
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          315..360
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          405..427
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        315..336
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        146
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z1W9,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         23..31
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z1W9,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         46
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000269|PubMed:14707132"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:22223895"
FT   MOD_RES         310
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         324
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         325
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         339
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18318008, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         347
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         359
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         427
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231"
FT   VARIANT         304
FT                   /note="T -> I (in dbSNP:rs6599079)"
FT                   /evidence="ECO:0000269|PubMed:10083736,
FT                   ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3"
FT                   /id="VAR_023232"
FT   VARIANT         425
FT                   /note="S -> T (in dbSNP:rs35295772)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_025181"
FT   VARIANT         433
FT                   /note="P -> S (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040969"
FT   MUTAGEN         46
FT                   /note="K->A: Loss of autophosphorylation and kinase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:14707132,
FT                   ECO:0000269|PubMed:16389068"
FT   MUTAGEN         46
FT                   /note="K->M: Loss of RELT, RELL1 and RELL2 phosphorylation.
FT                   Retention of some autophosphorylation activity may be due
FT                   to complex formation with other endogenous kinases in the
FT                   assay."
FT                   /evidence="ECO:0000269|PubMed:14707132,
FT                   ECO:0000269|PubMed:16389068"
FT   CONFLICT        316
FT                   /note="K -> R (in Ref. 5; AAP97192)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        325
FT                   /note="S -> G (in Ref. 5; AAP97192)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        363
FT                   /note="K -> R (in Ref. 5; AAP97192)"
FT                   /evidence="ECO:0000305"
FT   HELIX           14..16
FT                   /evidence="ECO:0007829|PDB:3DAK"
FT   STRAND          18..24
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   STRAND          31..35
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   TURN            37..40
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   STRAND          42..46
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   TURN            50..54
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   HELIX           57..65
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   STRAND          78..86
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   STRAND          88..93
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   HELIX           100..109
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   TURN            110..115
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   HELIX           120..139
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   HELIX           149..151
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   STRAND          152..154
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   STRAND          160..162
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   HELIX           166..170
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   HELIX           195..202
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   HELIX           207..222
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   TURN            226..229
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   HELIX           232..234
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   HELIX           235..240
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   TURN            247..250
FT                   /evidence="ECO:0007829|PDB:3DAK"
FT   HELIX           254..257
FT                   /evidence="ECO:0007829|PDB:3DAK"
FT   HELIX           262..271
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   HELIX           276..278
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   HELIX           282..286
FT                   /evidence="ECO:0007829|PDB:2VWI"
FT   HELIX           289..293
FT                   /evidence="ECO:0007829|PDB:3DAK"
FT   STRAND          434..441
FT                   /evidence="ECO:0007829|PDB:7OKW"
FT   STRAND          447..454
FT                   /evidence="ECO:0007829|PDB:7OKW"
FT   TURN            456..458
FT                   /evidence="ECO:0007829|PDB:7OKW"
FT   HELIX           461..470
FT                   /evidence="ECO:0007829|PDB:7OKW"
FT   HELIX           476..478
FT                   /evidence="ECO:0007829|PDB:7OKW"
FT   HELIX           479..491
FT                   /evidence="ECO:0007829|PDB:7OKW"
FT   TURN            493..495
FT                   /evidence="ECO:0007829|PDB:7OKW"
FT   STRAND          496..502
FT                   /evidence="ECO:0007829|PDB:7OKW"
FT   HELIX           504..506
FT                   /evidence="ECO:0007829|PDB:2V3S"
FT   STRAND          507..511
FT                   /evidence="ECO:0007829|PDB:2V3S"
FT   TURN            515..518
FT                   /evidence="ECO:0007829|PDB:7OKW"
FT   STRAND          519..526
FT                   /evidence="ECO:0007829|PDB:7OKW"
SQ   SEQUENCE   527 AA;  58022 MW;  B46EC934E95A3A1F CRC64;
     MSEDSSALPW SINRDDYELQ EVIGSGATAV VQAAYCAPKK EKVAIKRINL EKCQTSMDEL
     LKEIQAMSQC HHPNIVSYYT SFVVKDELWL VMKLLSGGSV LDIIKHIVAK GEHKSGVLDE
     STIATILREV LEGLEYLHKN GQIHRDVKAG NILLGEDGSV QIADFGVSAF LATGGDITRN
     KVRKTFVGTP CWMAPEVMEQ VRGYDFKADI WSFGITAIEL ATGAAPYHKY PPMKVLMLTL
     QNDPPSLETG VQDKEMLKKY GKSFRKMISL CLQKDPEKRP TAAELLRHKF FQKAKNKEFL
     QEKTLQRAPT ISERAKKVRR VPGSSGRLHK TEDGGWEWSD DEFDEESEEG KAAISQLRSP
     RVKESISNSE LFPTTDPVGT LLQVPEQISA HLPQPAGQIA TQPTQVSLPP TAEPAKTAQA
     LSSGSGSQET KIPISLVLRL RNSKKELNDI RFEFTPGRDT AEGVSQELIS AGLVDGRDLV
     IVAANLQKIV EEPQSNRSVT FKLASGVEGS DIPDDGKLIG FAQLSIS
//
